Arbuthnot Banking Group Plc Q&A with Hardman & Co (LON:ARBB)
12 August 2019
Revvity, Inc. (RVTY), a prominent player in the healthcare sector, operates within the diagnostics and research industry. Headquartered in Waltham, Massachusetts, Revvity offers a suite of health sciences solutions, technologies,..
iRhythm Holdings, Inc. (NASDAQ: IRTC) is capturing investor attention with its innovative approach to healthcare technology and substantial growth potential. As a leader in the medical devices industry, iRhythm offers..
Labcorp Holdings Inc. (NYSE: LH) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. The company stands out in its field, boasting a significant..
Stevanato Group S.p.A. (NYSE: STVN), a leading player in the healthcare sector, is drawing significant attention from investors due to its robust growth prospects and a remarkable potential upside of..
Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the healthcare sector, continues to capture attention with its diverse portfolio in the medical devices industry. Based in the United..
Illumina, Inc. (NASDAQ: ILMN) continues to be a fascinating player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $20.56 billion, Illumina is..
Investors have their eyes on Summit Therapeutics Inc. (NASDAQ: SMMT), a dynamic player in the biotechnology sector, as the company continues to make strides in developing groundbreaking therapies. With a..
Ascendis Pharma A/S (NASDAQ: ASND) is making waves in the biotechnology sector, offering promising growth prospects for investors keen on healthcare innovations. The Danish-based biopharmaceutical company is renowned for its..
Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector specializing in drug manufacturing, currently presents a noteworthy opportunity for investors, with its potential upside pegged at 7.22% based..
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, has been making waves in the healthcare industry with its innovative approaches to drug delivery. With a market..
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a commercial-stage biopharmaceutical company headquartered in Boston, Massachusetts, is drawing significant attention from investors. Specializing in rare neuroendocrine diseases, Rhythm Pharmaceuticals has a market capitalization..
Investors eyeing Centene Corporation (NYSE: CNC) may find themselves intrigued by the company’s substantial market presence in the healthcare sector, yet wary of its current valuation metrics and performance indicators...
Prestige Consumer Healthcare Inc. (NYSE: PBH), a key player in the healthcare sector, has drawn attention from investors with its strong portfolio of over-the-counter (OTC) health and personal care products...
Repligen Corporation (NASDAQ: RGEN), a key player in the healthcare sector focusing on medical instruments and supplies, presents a captivating investment opportunity with a notable potential upside of 44.7%. With..
BioNTech SE (NASDAQ: BNTX) stands as a beacon in the biotechnology industry, particularly known for its contributions to immunotherapy for cancer and infectious diseases. The German-based company, with a market..
Masimo Corporation (NASDAQ: MASI) stands at the forefront of the healthcare industry with its innovative medical devices and patient monitoring technologies. Based in Irvine, California, Masimo has carved out a..
Corcept Therapeutics Incorporated (NASDAQ: CORT) has recently caught the attention of investors, with an impressive potential upside of 83.19% as indicated by analyst target prices. This biopharmaceutical company, based in..
Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector, particularly within the medical devices industry, presents a compelling investment opportunity for those eyeing growth in the ever-evolving..
For investors with a keen eye on the biotechnology sector, BridgeBio Pharma, Inc. (NASDAQ: BBIO) presents an intriguing opportunity. With a market capitalization of $12.89 billion, this Palo Alto-based biopharmaceutical..
